Dr. Devendra Singh

Name: Dr. Devendra Singh

Designation: Scientist

Department: Pharmacology, AIIMS, New Delhi

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Educational Qualification:

M. Pharm (Pharmacology Toxicology and Therapeutics), from BVCOP, Navi Mumbai, University of Mumbai.

Ph.D. (Pharmacology) from All India Institute of Medical Sciences, New Delhi.

Awards:

Qualified GATE 2009

Qualified GPAT 2010, 2012 and 2013

Area of Interest:

Neuropharmacology, Ischemic Stroke, Alzheimer’s Disease, Preclinical research

List of Publications:

1. Joshi B*, Singh D*, Wasan H, Sharma U, Dinda AK, Reeta Kh. Tideglusib ameliorates ischemia/reperfusion damage by inhibiting GSK-3β and apoptosis in rat model of ischemic stroke. J. stroke Cerebrovasc. Dis. 2022 Apr;31(4):106349. (IF- 2.677) (* equal first authorship)
2. Wasan H*, Singh D*, Joshi B, Deept Upadhyay, Sharma U, Dinda AK, Reeta Kh. Dihydromyricetin alleviates cerebral ischemia-reperfusion injury by attenuating apoptosis and astrogliosis in peri-infarct cortex. Neur. Res. 2021 Dec 9;1-12. doi: 10.1080/01616412.2021.1997010. (IF-2.529) (* equal first authorship)
3. Wasan H, Singh D, Joshi B, Sharma U, Dinda AK, Reeta Kh. Post stroke safinamide treatment attenuates neurological damage by modulating autophgy and apoptosis in experimental model of stroke in rats. Mol. Neurob. 2021 Aug 28. doi: 10.1007/s12035-021-02523-6. (IF-5.682)
4. Singh D, Wasan H, Reeta KH. Preclinical Stroke Research and Translational Failure: A Bird’s Eye View on Preventable Variables. Cell. Mol. Neurobiology. 2021 doi.org/10.1007/s10571-021-01083-6. (IF-4.231)
5. Wasan H, Singh D, Kh R. Safinamide in neurological disorders and beyond: evidence from preclinical and clinical studies. Brain Res. Bull. 2020 Dec 30: S0361-9230(20) 30735-8. (IF-3.715)
6. Verma V*, Singh D*, Reeta KH. Sinapic acid alleviates oxidative stress and neuro-inflammatory changes in sporadic model of Alzheimer’s disease in rats. Brain Sciences, 2020 Nov; 10(12): 923. (IF-3.333) (* equal first authorship)
7. Singh D, Wasan H, Reeta KH. Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications. Free Radic. Biol. Med. 2020 Oct 19;161:263-271. (IF-8.101)
8. Singh D, Wasan H, Mathur A, Gupta YK. Indian perspective of remdesivir: A promising COVID-19 drug. Indian J. Pharmacol. 2020 May-Jun;52(3): 227-228. (IF-2.833)
9. Singh D, Reeta KH, Sharma U, Jagannathan NR, Dinda AK, Gupta YK. Neuro-protective effect of monomethyl fumarate on ischemia reperfusion injury in rats Role of Nrf2HO1 pathway in peri-infarct region. Neurochem. Int. 2019 June; 126: 96-108. (IF-4.297)
10. Reeta KH, Singh D, Gupta YK. Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation. Neurochem. Int. 2017 Sep; 108: 146-156. (IF-4.297)